To support the global effort to develop and manufacture safe and effective COVID-19 vaccines and treatments, innovative biopharmaceutical companies will continue to work with all relevant stakeholders on three overarching priorities and supporting activities.
Read moreAs heads of state and government gathered at the 35th African Union Summit (5-6 February 2022), IFPMA as part of the African Medicines Agency Treaty Alliance (AMATA) applauded the momentum reached so far on the ratification and implementation of the AMA.
Read more
This information is a culmination of clinical development data and post-marketing learnings and data, translated into descriptive text for Healthcare Professionals (HCPs) and in some cases specifically for the patient.
Read more
In our third Progress Report, Alliance members provide detailed data presenting valuable insights into industry progress on AMR and show some encouraging areas of progress and innovation.
Read more
Today the AMR Industry Alliance released its latest Progress Report, reflecting on collective achievements from the life sciences industry to minimize the spread of antimicrobial resistance (AMR).
Read moreIndustry welcomes the progress made so far in influenza preparedness, although we wish to call out 3 key policy areas where much work still needs to be done: 1) improving seasonal influenza vaccine coverage, 2) addressing the increasing challenges and barriers being posed by national ABS legislation in accessing pathogen samples, and 3) in finally...
Read moreDrawing on the findings of a recent report launched under the Business Ethics for APEC SMEs Initiative, Thomas Cueni outlines the benefits for small and medium-sized enterprises (SMEs) of adopting ethical practices.
Read moreIFPMA and the Global Self-Care Federation (GSCF) support the draft decision on NCDs presented to the 150th Executive Board and strongly believes that concerted efforts are required to keep NCDs at the top of the global health agenda. Whilst the world has been occupied over the last two years with tackling the pandemic, COVID-19 has...
Read moreGeneva, 24 January 2022: The global health community recently celebrated the first billion doses of vaccines delivered through COVAX. This would not have been possible without unprecedented collaboration and partnerships involving private companies, international agencies, governments, and health workers from industrialized and developing countries. A year since the first COVID-19 vaccine was administered, vaccine makers including...
Read moreThe Africa Young Innovators for Health Award is IFPMA and Speak Up Africa’s flagship programme. The Award focuses on supporting young healthcare entrepreneurs across Africa with opportunities to develop their business ideas and advance promising solutions to improve healthcare systems across Africa.
Read more
In response to the persistent gender disparities in Africa’s healthcare innovation space, IFPMA and Speak Up Africa, partners of the Africa Young Innovators for Health Award, launched the Women Innovators Incubator program. The initiative focuses on providing a supportive environment for women entrepreneurs to create and grow high-impact and sustainable solutions to Africa’s most pressing healthcare needs.
Read more
The scale and threat of antimicrobial resistance is much bigger and more imminent than previously anticipated. New evidence shows that, in 2019, the global burden associated with drug-resistant infections was an estimated 4.95 million deaths, of which AMR was the direct cause of at least 1.27 million deaths. This number is only set to grow...
Read more